Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease

Blood

Volumn 120, Issue 25, 2012, Pages 5050-5058

  Camus, Stéphane M ^a   Gausserès, Blandine ^a   Bonnin, Philippe ^b   Loufrani, Laurent ^c   Grimaud, Linda ^c   Charue, Dominique ^a   De Moraes, Joao A ^a   Renard, Jean Marie ^a   Tedgui, Alain ^a   Boulanger, Chantal M ^a   Tharaux, Pierre Louis ^a   Blanc Brude, Olivier P ^a  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; LIPOCORTIN 5; PEPTIDE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; THROMBOSPONDIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; ECHINOCYTE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ERYTHROCYTE; ERYTHROCYTE MICROPARTICLE; EXPERIMENTAL MODEL; FLUORESCENCE ACTIVATED CELL SORTING; IN VITRO STUDY; MALE; MEMBRANE MICROPARTICLE; MICROVASCULATURE; MONOLAYER CULTURE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SICKLE CELL ANEMIA; VASODILATATION;

EID: 84871055427     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-413138     Document Type: Article

References (49)

1. Allan D, Limbrick AR, Thomas P, Westerman MP. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature. 1982; 295(5850):612-613.
2. Warth JA, Rucknagel DL. Density ultracentrifugation of sickle cells during and after pain crisis: increased dense echinocytes in crisis. Blood. 1984; 64(2):507-515. (Pubitemid 14051340)
3. Chabanel A, Reinhart W, Chien S. Increased resistance to membrane deformation of shapetransformed human red blood cells. Blood. 1987; 69(3):739-743. (Pubitemid 17057449)
4. Nath KA, Katusic ZS. Vasculature and kidney complications in sickle cell disease. J Am Soc Nephrol. 2012;23(5):781-784.
5. Wun T, Paglieroni T, Tablin F,Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 1997;129(5):507-516. (Pubitemid 27285047)
6. Setty BN, Kulkarni S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96(3):1119-1124. (Pubitemid 30616882)
7. Westerman M, Pizzey A, Hirschman J, et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol. 2008;142(1):126-135. (Pubitemid 351783151)
8. Mahfoudhi E, Lecluse Y, Driss F, Abbes S, Flaujac C, Garcon L. Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles. Br J Haematol. 2012; 156(4):545-547.
9. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102(7):2678-2683. (Pubitemid 37193612)
10. van Tits LJ, van Heerde WL, Landburg PP, et al. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis. Biochem Biophys Res Commun. 2009;390(1):161-164.
11. van Beers EJ, Schaap MC, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009;94(11):1513-1519.
12. Browne PV, Mosher DF, Steinberg MH, Hebbel RP. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol. 1996; 51(4):296-301. (Pubitemid 26116369)
13. Beurling-Harbury C, Schade SG. Platelet activation during pain crisis in sickle cell anemia patients. Am J Hematol. 1989;31(4):237-241. (Pubitemid 19188518)
14. Bonnefoy A, Daenens K, Feys HB, et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood. 2006;107(3):955-964. (Pubitemid 43156292)
15. Bonnefoy A, Moura R, Hoylaerts MF. The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell Mol Life Sci. 2008;65(5):713-727.
16. McLaughlin JN, Mazzoni MR, Cleator JH, et al. Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells. J Biol Chem. 2005; 280(23):22172-22180. (Pubitemid 40827873)
17. Phelan MW, Forman LW, Perrine SP, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med. 1998;132(6):519-529. (Pubitemid 28564710)
18. Frangogiannis NG, Ren G, Dewald O, et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005;111(22):2935-2942. (Pubitemid 40814186)
19. Sajid M, Hu Z, Guo H, Li H, Stouffer GA. Vascular expression of integrin-associated protein and thrombospondin increase after mechanical injury. J Investig Med. 2001;49(5):398-406. (Pubitemid 32777003)
20. McPherson J, Sage H, Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin. J Biol Chem. 1981;256(21):11330-11336. (Pubitemid 12219997)
21. Freyberg MA, Kaiser D, Graf R, Buttenbender J, Friedl P. Proatherogenic flow conditions initiate endothelial apoptosis via thrombospondin-1 and the integrin-associated protein. Biochem Biophys Res Commun. 2001;286(1):141-149. (Pubitemid 32917661)
22. Moura R, Tjwa M, Vandervoort P, Cludts K, Hoylaerts MF. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler Thromb Vasc Biol. 2007;27(10):2163-2169. (Pubitemid 350287245)
23. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood. 1993;81(8):2137-2143. (Pubitemid 23106730)
24. Brittain JE, Mlinar KJ, Anderson CS, Orringer EP, Parise LV. Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin. Blood. 2001;97(7):2159-2164. (Pubitemid 32241808)
25. Brittain JE, Mlinar KJ, Anderson CS, Orringer EP, Parise LV. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J Clin Invest. 2001; 107(12):1555-1562. (Pubitemid 32577083)
26. Brittain JE, Han J, Ataga KI, Orringer EP, Parise LV. Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes. J Biol Chem. 2004;279(41):42393-42402. (Pubitemid 39372121)
27. Trudel M, Saadane N, Garel MC, et al. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J. 1991;10(11):3157-3165. (Pubitemid 21905338)
28. Kosfeld MD, Frazier WA. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. J Biol Chem. 1993; 268(12):8808-8814. (Pubitemid 23118671)
29. Bonnin P, Sabaa N, Flamant M, Debbabi H, Tharaux PL. Ultrasound imaging of renal vaso-occlusive events in transgenic sickle mice exposed to hypoxic stress. Ultrasound Med Biol. 2008;34(7):1076-1084. (Pubitemid 351902240)
30. Sabaa N, de Franceschi L, Bonnin P, et al. Endothelin receptor antagonism prevents hypoxiainduced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest. 2008;118(5):1924-1933. (Pubitemid 351632394)
31. Leroyer AS, Ebrahimian TG, Cochain C, et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation. 2009; 119(21):2808-2817.
32. Loufrani L, Levy BI, Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res. 2002;91(12):1183-1189. (Pubitemid 36076368)
33. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem. 1996;271(1):21-24. (Pubitemid 26026555)
34. McDonald JF, Dimitry JM, FrazierWA.An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs. Biochemistry. 2003;42(33):10001-10011. (Pubitemid 37012876)
35. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem. 2006;281(36):26069-26080. (Pubitemid 44401813)
36. Floquet N, Dedieu S, Martiny L, Dauchez M, Perahia D. Human thrombospondin's (TSP-1) C-terminal domain opens to interact with the CD-47 receptor: a molecular modeling study. Arch Biochem Biophys. 2008;478(1):103-109.
37. Lim HWG, Wortis M, Mukhopadhyay R. Stomatocyte-discocyte-echinocyte sequence of the human red blood cell: evidence for the bilayer-couple hypothesis from membrane mechanics. Proc Natl Acad Sci U S A. 2002;99(26):16766-16769. (Pubitemid 36034047)
38. Mukhopadhyay R, Lim HWG, Wortis M. Echinocyte shapes: bending, stretching, and shear determine spicule shape and spacing. Biophys J. 2002;82(4):1756-1772. (Pubitemid 34280793)
39. Bratosin D, Estaquier J, Petit F, et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ. 2001;8(12):1143-1156. (Pubitemid 34048470)
40. Schwartz MA, Brown EJ, Fazeli B. A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol Chem. 1993;268(27):19931-19934. (Pubitemid 23278883)
41. Tsao PW, Mousa SA. Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly- Asp and carboxyl-terminal domains. J Biol Chem. 1995;270(40):23747-23753.
42. Mateo V, Brown EJ, Biron G, et al. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood. 2002;100(8):2882-2890.
43. Roué G, Bitton N, Yuste VJ, et al. Mitochondrial dysfunction in CD47-mediated caspase-independent cell death: ROS production in the absence of cytochrome c and AIF release. Biochimie. 2003;85(8):741-746. (Pubitemid 37383792)
44. Head DJ, Lee ZE, Swallah MM, Avent ND. Ligation of CD47 mediates phosphatidylserine expression on erythrocytes and a concomitant loss of viability in vitro. Br J Haematol. 2005;130(5):788-790. (Pubitemid 43906652)
45. Sakthivel R, Farooq SM, Kalaiselvi P, Varalakshmi P. Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure. Clin Chim Acta. 2007; 382(1-2):1-7. (Pubitemid 46782724)
46. Iglic A, Veranic P, Jezernik K, et al. Spherocyte shape transformation and release of tubular nanovesicles in human erythrocytes. Bioelectrochemistry. 2004;62(2):159-161. (Pubitemid 38376157)
47. Pászty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997; 278(5339):876-878. (Pubitemid 27467927)
48. Wu LC, Sun CW, Ryan TM, Pawlik KM, Ren J, Townes TM. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 2006;108(4):1183-1188. (Pubitemid 44232013)
49. Willekens FL, Werre JM, Kruijt JK, et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood. 2005;105(5):2141-2145. (Pubitemid 40731805)